Items | Study group* | Control group** | X2 | P |
WBC (*109/L) | 8.04 ± 3.15 | 8.66 ± 4.27 | 0.89 | 0.37a |
Hb (g/L) | 126.10 ± 20.84 | 123.46 ± 19.74 | 0.71 | 0.48 |
PLT (*109/L) | 260.05 ± 87.76 | 251.83 ± 94.94 | 0.49 | 0.63 |
D-dimer (ng/mL) | 5.142 ± 5.70 | 1.327 ± 2.54 | 4.70 | 0.00 |
CEA (ng/mL) | 64.18 ± 218.9 | 63.54 ± 112.6 | 0.02 | 0.98 |
SCC (ng/mL) | 3.54 ± 9.38 | 2.24 ± 4.88 | 0.95 | 0.35 |
NSE (ng/mL) | 18.37 ± 12.61 | 21.21 ± 14.03 | −1.01 | 0.31a |
pro-GRP (ng/mL) | 46.96 ± 35.77 | 37.09 ± 17.62 | 1.91 | 0.61a |
CYFRA21-1 (pg/mL) | 9.68 ± 7.93 | 11.28 ± 24.85 | −0.47 | 0.64 |